Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Jasper collaborates with NIAID to evaluate JSP-191 in chronic granulomatous disease

May 27, 2021

Xilio and Merck & Co. collaborate on anti-CTLA-4 MAb program

May 26, 2021

Boehringer Ingelheim accepts DCR-LIV2 as development candidate under Dicerna agreement

May 26, 2021

CARB-X grant supports Basilea's development of small-molecule inhibitors of DXR

May 20, 2021

Dr. Reddy's licenses anti-BCMA CAR T PRG-1801 for India

May 14, 2021

Checkmate and Regeneron enter agreement to evaluate vidutolimod plus cemiplimab

May 11, 2021

DarwinHealth and Bristol Myers Squibb establish Novel Cancer Target Initiative

May 7, 2021

XBiotech and INSERM collaborate on phase II/III trial of XB-2001

May 4, 2021

Cereno and University of Michigan collaborate on preclinical development of CS-585

April 30, 2021

ESSA and Bayer enter clinical collaboration to evaluate EPI-7386 plus darolutamide in mCRPC

April 29, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...